EICHOR
● Active Not Recruiting
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
Condition: Arthritis, Psoriatic · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) by assessing the reduction in signs and symptoms of PsA.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (280)
| Rheumatology Associates | Birmingham, Alabama, United States | — |
| Arizona Arthritis and Rheumatology Research PLLC | Flagstaff, Arizona, United States | — |
| Arizona Arthritis & Rheumatology Associates PC | Glendale, Arizona, United States | — |
| Arizona Arthritis & Rheumatology Research, PLLC | Tucson, Arizona, United States | — |
| Advanced Medical Research | La Palma, California, United States | — |
| Rheumatology Center of San Diego | San Diego, California, United States | — |
| Medvin Clinical Research, Inc. | Whittier, California, United States | — |
| Heuer M.D. Research | Orlando, Florida, United States | — |
| The Arthritis Center, Inc. | Palm Harbor, Florida, United States | — |
| Forcare Clinical Research Inc | Tampa, Florida, United States | — |
| Klein And Associates M D P A | Hagerstown, Maryland, United States | — |
| Advanced Rheumatology | Okemos, Michigan, United States | — |
+ 268 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04882098